PurposeAchieving organizational-level outcomes through human resource practices (HRP) as the basis of nearly all organizational improvements has remained relatively unexplored, which requires more investigations. Therefore, the present study aimed to develop a framework to theorize how high-performance work systems (HPWS) can provide organizations with critical instruments for organizational learning (OL) creation that in turn leads to innovation performance (IP).Design/methodology/approachSurvey-based, multisource research was designed to examine the proposed model, using the data collected from 154 pharmaceutical industry-related companies.FindingsAccording to the study results, HPWS concentrating on enhancing practices of abilities, motivations and opportunities (AMO) were positively associated with OL, which could in turn improve IP. Moreover, innovation culture (IC) showed a significant moderating effect on the association between OL and IP.Originality/valueThe central originality of this research first is that HPWS acts as antecedents of OL capabilities contributing to firm-level IP; second, the relationship between OL and firm IP is contingent upon the level of IC in organizations.

No abstract

digital health solutions. Published MIBs outlined evidence from both real world observational studies and controlled trials. CONCLUSIONS: Although noncompulsory, the number of published MIBs is rising, suggesting an increasing focus on new innovations within the UK NHS. MIBs provide a forum for communicating the effectiveness, safety, costs and resource implications of medical technology solutions across a range of applications. Since MIBs do not include recommendations, more detailed guidance is needed to help manufacturers develop robust evidence-bases and assist stakeholders with decision-making regarding which are the most clinically-effective, resource-efficient and/or cost-effective options in comparison with standard care.

No abstract